Coleman Research has built genuinely deep healthcare and life-sciences coverage disproportionate to their overall size. FieldSignal sits adjacent — broader sector coverage, EU-jurisdictional, no retainer requirement. Here's the honest pick.
Pick Coleman if healthcare is the dominant share of your research diet. Pick FieldSignal if your sector mix is broader and you want EU contracting.
Send us your last 12 months of Coleman briefs by sector
We'll quote against your blended rate including any healthcare projects
Test on one non-healthcare project to compare bench depth
Sign single EU MSA — no annual commit
First call inside 72h
Can FieldSignal match Coleman on healthcare depth?
Not on healthcare specifically. Coleman's life-sciences bench is genuinely deeper than ours. If healthcare is your dominant sector, Coleman is the right answer.
What about non-healthcare sectors?
We're broadly stronger on industrials, EU tech and services. Coleman's coverage outside healthcare is solid but not their strength.
Why does EU contracting matter?
If you're an EU-domiciled fund, signing with an EU-domiciled boutique simplifies GDPR data-processor arrangements. Coleman's US contracting works but adds documentation friction.
Is Coleman's retainer worth it at mid-market scale?
If you run >$30k annual healthcare research, yes. Below that threshold, FieldSignal's no-minimum model is materially more efficient.
Honest head-to-head on price, network depth, turnaround and compliance. When GLG is right. When FieldSignal is.
Where AlphaSights' speed and account model wins. Where FieldSignal's per-call pricing and senior contact win. Honest comparison.
Third Bridge's Forum library vs FieldSignal's custom calls + lightweight transcripts. Where each genuinely wins.